290 related articles for article (PubMed ID: 30635402)
1. Casein kinase II-dependent phosphorylation of DNA topoisomerase II suppresses the effect of a catalytic topo II inhibitor, ICRF-193, in fission yeast.
Nakazawa N; Arakawa O; Ebe M; Yanagida M
J Biol Chem; 2019 Mar; 294(10):3772-3782. PubMed ID: 30635402
[TBL] [Abstract][Full Text] [Related]
2. ICRF-193, an anticancer topoisomerase II inhibitor, induces arched telophase spindles that snap, leading to a ploidy increase in fission yeast.
Nakazawa N; Mehrotra R; Arakawa O; Yanagida M
Genes Cells; 2016 Sep; 21(9):978-93. PubMed ID: 27458047
[TBL] [Abstract][Full Text] [Related]
3. Analyzing Mitotic Chromosome Structural Defects After Topoisomerase II Inhibition or Mutation.
Giménez-Abián JF; Lane AB; Clarke DJ
Methods Mol Biol; 2018; 1703():191-215. PubMed ID: 29177744
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events.
Ishida R; Sato M; Narita T; Utsumi KR; Nishimoto T; Morita T; Nagata H; Andoh T
J Cell Biol; 1994 Sep; 126(6):1341-51. PubMed ID: 8089169
[TBL] [Abstract][Full Text] [Related]
5. Ku antigen is required to relieve G2 arrest caused by inhibition of DNA topoisomerase II activity by the bisdioxopiperazine ICRF-193.
Muñoz P; Baus F; Piette J
Oncogene; 2001 Apr; 20(16):1990-9. PubMed ID: 11360183
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic evidence that DNA topoisomerase II is not involved in radiation induced chromsome-type aberrations.
Mosesso P; Pepe G; Ottavianelli A; Schinoppi A; Cinelli S
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():14-8. PubMed ID: 26520368
[TBL] [Abstract][Full Text] [Related]
7. Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.
Grozav AG; Chikamori K; Kozuki T; Grabowski DR; Bukowski RM; Willard B; Kinter M; Andersen AH; Ganapathi R; Ganapathi MK
Nucleic Acids Res; 2009 Feb; 37(2):382-92. PubMed ID: 19043076
[TBL] [Abstract][Full Text] [Related]
8. DNA topoisomerase 2 mutant allele mildly delays the mitotic progression and activates the checkpoint protein kinase Chk1 in fission yeast Schizosaccharomyces pombe.
Yadav S; Verma SK; Ahmed S
Genet Res (Camb); 2011 Aug; 93(4):275-83. PubMed ID: 21767457
[TBL] [Abstract][Full Text] [Related]
9. Topoisomerase II SUMOylation activates a metaphase checkpoint via Haspin and Aurora B kinases.
Pandey N; Keifenheim D; Yoshida MM; Hassebroek VA; Soroka C; Azuma Y; Clarke DJ
J Cell Biol; 2020 Jan; 219(1):. PubMed ID: 31712254
[TBL] [Abstract][Full Text] [Related]
10. The Catalytic Subunit of
Rojas DA; Urbina F; Solari A; Maldonado E
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012759
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of serine 1106 in the catalytic domain of topoisomerase II alpha regulates enzymatic activity and drug sensitivity.
Chikamori K; Grabowski DR; Kinter M; Willard BB; Yadav S; Aebersold RH; Bukowski RM; Hickson ID; Andersen AH; Ganapathi R; Ganapathi MK
J Biol Chem; 2003 Apr; 278(15):12696-702. PubMed ID: 12569090
[TBL] [Abstract][Full Text] [Related]
12. The regulation of DNA topoisomerase II by casein kinase II.
Alghisi GC; Roberts E; Cardenas ME; Gasser SM
Cell Mol Biol Res; 1994; 40(5-6):563-71. PubMed ID: 7735331
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the DNA topoisomerase II catalytic inhibitor meso-2,3-bis(3,5-dioxopiperazine-1-yl)butane (ICRF-193), a bisdioxopiperazine derivative, with the conserved region(s) of eukaryotic but not prokaryotic enzyme.
Sato M; Ishida R; Narita T; Kato J; Ikeda H; Fukazawa H; Andoh T
Biochem Pharmacol; 1997 Sep; 54(5):545-50. PubMed ID: 9337070
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of the C-terminal domain of yeast topoisomerase II by casein kinase II affects DNA-protein interaction.
Dang Q; Alghisi GC; Gasser SM
J Mol Biol; 1994 Oct; 243(1):10-24. PubMed ID: 7932731
[TBL] [Abstract][Full Text] [Related]
15. MCPH1 Lack of Function Enhances Mitotic Cell Sensitivity Caused by Catalytic Inhibitors of Topo II.
Arroyo M; Sánchez A; Cañuelo A; Heredia-Molina RF; Martínez-Molina E; Clarke DJ; Marchal JA
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32276518
[TBL] [Abstract][Full Text] [Related]
16. Condensin phosphorylated by the Aurora-B-like kinase Ark1 is continuously required until telophase in a mode distinct from Top2.
Nakazawa N; Mehrotra R; Ebe M; Yanagida M
J Cell Sci; 2011 Jun; 124(Pt 11):1795-807. PubMed ID: 21540296
[TBL] [Abstract][Full Text] [Related]
17. DNA topoisomerase II-dependent control of the cell cycle progression in root meristems of Allium cepa.
Zabka A; Polit JT; Bernasińska J; Maszewski J
Cell Biol Int; 2014 Mar; 38(3):355-67. PubMed ID: 24302674
[TBL] [Abstract][Full Text] [Related]
18. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
19. Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha.
Patel S; Jazrawi E; Creighton AM; Austin CA; Fisher LM
Mol Pharmacol; 2000 Sep; 58(3):560-8. PubMed ID: 10953049
[TBL] [Abstract][Full Text] [Related]
20. A casein kinase type II (CKII)-like nuclear protein kinase associates with, phosphorylates, and activates topoisomerase I.
Turman MA; Douvas A
Biochem Med Metab Biol; 1993 Oct; 50(2):210-25. PubMed ID: 8260198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
